Update on the neurology of Parkinson's disease

Neurourology and Urodynamics

Volumn 26, Issue 1, 2007, Pages 103-109

  Fowler, Clare J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

LUTS; Neurology; Parkinson's disease

Indexed keywords

AMANTADINE; APOMORPHINE; BENZATROPINE; BROMOCRIPTINE; CABERGOLINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ORPHENADRINE; PERGOLIDE; PHOSPHODIESTERASE INHIBITOR; PRAMIPEXOLE; ROPINIROLE; SILDENAFIL; TOLCAPONE;

AUTONOMIC DYSFUNCTION; BASAL GANGLION; BLADDER DYSFUNCTION; BRAIN ATROPHY; CEREBELLAR ATAXIA; CONFUSION; CONSTIPATION; CYSTOMETRY; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DYSKINESIA; ELECTROMYOGRAPHY; ERECTILE DYSFUNCTION; HALLUCINATION; HUMAN; INSOMNIA; LOWER URINARY TRACT SYMPTOM; MEMORY DISORDER; MICTURITION REFLEX; NAUSEA; NEUROPATHOLOGY; NIGHTMARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PONS; PROSTATE SURGERY; PSYCHOSIS; RETROPERITONEAL FIBROSIS; REVIEW; SHY DRAGER SYNDROME; SIDE EFFECT; SYMPATHETIC INNERVATION; SYSTEMATIC REVIEW; URINARY URGENCY; URINE COLOR; VOMITING; XEROSTOMIA;

HUMANS; NEUROLOGY; PARKINSON DISEASE; URINARY BLADDER DISEASES; UROLOGY;

EID: 33846632292     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20371     Document Type: Review

References (45)

1. Araki I, Kuno S. 2000. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 68:429-33.
2. Araki I, Kitahara M, Oida T, et al. 2000. Voiding dysfunction and Parkinson's disease: Urodynamic abnormalities and urinary symptoms. J Urol 164:1640-3.
3. Beck RO, Betts CD, Fowler CJ. 1994. Genito-urinary dysfunction in Multiple System Atrophy: Clinical features and treatment in 62 cases. J Urol 151:1336-41.
4. Benarroch EE. 2003. Brainstem in multiple system atrophy: Clinicopathological correlations. Cell Mol Neurobiol 23:519-26.
5. Braak H, Rub U, Sandmann-Keil D, et al. 2000. Parkinsons disease: Affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol(Berl) 99:489-95.
6. Braak H, Ghebremedhin E, Rub U, et al. 2004. Stages in the development of Parkinsons disease-related pathology. Cell Tissue Res 318:121-34.
7. Chandiramani VA, Palace J, Fowler CJ. 1997. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 80:100-4.
8. Christmas T, Kempster P, Chapple C, et al. 1988. Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet 2:1451-3.
9. Dmochowski RR. 1999. Female voiding dysfunction and movement disorders. Int Urogynecol J 10:144-51.
10. Finazzi-Agro E, Peppe A, D'Amico A, et al. 2003. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J Urol 169:1388-91.
11. Fitzmaurice H, Fowler C, Rickards D, et al. 1985. Micturition disturbance in Parkinson's disease. Br J Urol 57:652-6.
12. Giovannoni G, O'Sullivan JD, Turner K, et al. 2000. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423-8.
13. Hahn K, Ebersbach G. 2005. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease. Mov Disord 20:1499-502.
14. Hashimoto K, Oyama T, Sugiyama T, et al. 2003. Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats. J Pharmacol Sci 92:143-8.
15. Healy DG, Abou-Sleiman PM, Quinn N, et al. 2005. UCHL-1 gene in multiple system atrophy: A haplotype tagging approach. Mov Disord 20:1338-43.
16. Hussain I, Brady C, Swinn M, et al. 2001. Exacerbation of orthostatic hypotension with sildenafil citrate (Viagra) in patients with autonomic failure due to multiple system atrophy (MSA). J Neurol Neurosurg Psychiatry 71:371-4.
17. Ito T, Sakakibara R, Yasuda K, et al. 2006. Incomplete emptying and urinary retention in multiple system atrophy: When does it occur and how do we manage it? Mov Disord 21:816-23.
18. Kirby RS, Fowler CJ, Gosling JA, et al. 1985. Bladder dysfunction in distal autonomic neuropathy of acute onset. J Neurol Neurosurg Psychiatry 48:762-7.
19. Kirchhof K, Apostolidis AN, Mathias CJ, et al. 2003. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: A retrospective study. Int J Impot Res 15:293-8.
20. Kitta T, Kakizaki H, Furuno T, et al. 2006. Brain activation during detrusor overactivity in patients with Parkinson's disease: A positron emission tomography study. J Urol 175:994-8.
21. Mannen T, Iwata M, Toyokura Y, et al. 1982. The Onuf's nucleus and the external anal sphincter muscle in ALS and Shy-Drager syndrome. Acta Neuropathol 58:255-60.
22. Oertel WH, Wachter T, Quinn NP, et al. 2003. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord 18:430-2.
23. Oppenheimer DR. 1980. Lateral horn cells in progressive autonomic failure. J Neurol Sci 46:393-404.
24. Ozawa T, Paviour D, Quinn NP, et al. 2004. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations. Brain 127:2657-71.
25. Palace J, Chandiramani VA, Fowler CJ. 1997. Value of sphincter EMG in the diagnosis of Multiple System Atrophy. Muscle Nerve 20:1396-403.
26. Paviour DC, Williams D, Fowler CJ, et al. 2005. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis. Mov Disord 20:1425-30.
27. Paviour DC, Price SL, Jahanshahi M, et al. 2006. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: Rates and regions of atrophy. Brain 129:1040-49.
28. Popat R, Apostolidis A, Kalsi V, et al. 2005. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174:984-8.
29. Quinn N. 1995. Parkinsonism-Recognition and differential diagnosis. Br Med J 310:447-52.
30. Sakakibara R, Hattori T, Tojo M, et al. 1993. Micturitional disturbance in multiple system atrophy. Jpn J Psychiatry Neurol 47:591-8.
31. Sakakibara R, Hattori T, Uchiyama T, et al. 2000. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: Which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 68:65-9.
32. Sakakibara R, Shinotoh H, Uchiyama T, et al. 2001a. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 92:76-85.
33. Sakakibara R, Shinotoh H, Uchiyama T, et al. 2001b. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction. J Neurol Sci 187:55-9.
34. Schmid DM, Sauermann P, Werner M, et al. 2006. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176:177-85.
35. Schurch B, Stohrer M, Kramer G, et al. 2000. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692-7.
36. Seif C, Herzog J, van der Horst C, et al. 2004. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 55:118-20.
37. Seki S, Igawa Y, Kaidoh K, et al. 2001. Role of Dopamine D1 and D1 receptors in the micturition reflex in conscious rats. Neurourol Urodyn 20:105-13.
38. Staskin DS, Vardi Y, Siroky MA. 1988. Post-prostatectomy incontinence in the parkinsonian patient: The significance of poor voluntary sphincter control. J Urol 140:117-8.
39. Uchiyama T, Sakakibara R, Hattori T, et al. 2003. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Mov Disord 18:573-8.
40. Vodusek DB. 2001. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 16:600-7.
41. Wenning GK, Ben Shlomo Y, Magalhaes M, et al. 1994. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117:835-45.
42. Winge K, Fowler CJ. 2006. Bladder dysfunction in Parkinsonism: Mechanisms, prevalence, symptoms, and management. Mov Disord 21:737-45.
43. Winge K, Friberg L, Werdelin L, et al. 2005. Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease. Eur J Neurol 12:842-50.
44. Yoshimura N, Sas M, Yoshida O, et al. 1992. Dopamine D1 receptor-mediated inhibition of micturition reflex by central dopamine from the substantia nigra. Neurourol Urodyn 11:535-45.
45. Zhang H, Reitz A, Kollias S, et al. 2005. An fMRI study of the role of suprapontine brain structures in the voluntary voiding control induced by pelvic floor contraction. Neuroimage 24:174-80.